Personalized Pain Management Systems with Adaptive Intranasal Lidocaine Delivery

A next-generation pain management system integrating wearable devices, AI-powered algorithms, and preservative-free intranasal lidocaine dispensers to provide personalized, adaptive, and real-time pain treatment.

The original patent disclosed a preservative-free intranasal composition for treating various pain conditions. However, it lacked personalization and adaptability, relying on fixed dosing regimens. The new inventive concept addresses this limitation by introducing wearable devices, AI-driven algorithms, and real-time feedback mechanisms to optimize pain treatment for individual patients.

The system comprises a wearable device detecting pain patterns, a neural network-based algorithm predicting optimal dosing regimens, and a preservative-free intranasal composition dispenser. The dispenser releases customized doses of lidocaine based on the detected pain patterns, medical histories, and real-time pain feedback. The system can be integrated with mobile applications, cloud-based servers, and biofeedback-controlled transnasal lidocaine delivery systems to provide a comprehensive pain management platform.

The new claims introduce wearable devices, AI-powered algorithms, and real-time feedback mechanisms, which are novel and non-obvious compared to the original patent. These innovations enable personalized, adaptive, and real-time pain treatment, distinguishing the new inventive concept from existing solutions.

Alternative embodiments may include using different wearable devices, such as smartwatches or implantable sensors, or integrating the system with other pain management modalities, such as electrical stimulation or pharmacogenomics. Variations may also involve using different AI algorithms or machine learning models to predict optimal dosing regimens.

The inventive concept has significant commercial potential in the pain management market, particularly in the areas of chronic pain, neuropathic pain, and migraines. The system's adaptability and personalization capabilities can improve treatment outcomes, reduce healthcare costs, and enhance patient quality of life. Target industries include pharmaceutical companies, medical device manufacturers, and healthcare providers.